2-methoxyestradiol has been researched along with Cancer of Pituitary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Du, G; Huang, L; Xiao, Z; Zhao, Y | 1 |
1 other study(ies) available for 2-methoxyestradiol and Cancer of Pituitary
Article | Year |
---|---|
HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression.
Topics: 2-Methoxyestradiol; Adult; Animals; Antineoplastic Agents, Alkylating; Cell Survival; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Pituitary Neoplasms; Temozolomide; Tumor Suppressor Proteins | 2013 |